|
liver transplantation |
26 |
|
hepatocellular carcinoma |
25 |
|
medical sciences |
16 |
|
gastroenterology |
14 |
|
outcomes |
14 |
|
meld |
12 |
|
acute flare |
11 |
|
decompensation |
11 |
|
gastroenterology medical sciences |
11 |
|
liver failure |
11 |
|
surgery |
11 |
|
bile ducts - surgery |
8 |
|
carcinoma, hepatocellular - complications/diagnosis - surgery |
8 |
|
hepatectomy - methods |
8 |
|
liver neoplasms - complications/diagnosis - surgery |
8 |
|
stereotactic body radiation therapy |
8 |
|
thrombosis - diagnosis - etiology - surgery |
8 |
|
transarterial chemoembolization |
8 |
|
unresectable |
8 |
|
abdominal abscess |
7 |
|
abdominal bleeding |
7 |
|
adult |
7 |
|
body mass index |
7 |
|
cancer staging |
7 |
|
cancer survival |
7 |
|
cap |
7 |
|
de novo hbv |
7 |
|
de novo hepatocellular carcinoma |
7 |
|
entecavir |
7 |
|
extended criteria organ |
7 |
|
graft-to-recipient weight ratio |
7 |
|
hepatitis b infection |
7 |
|
hepatitis b vaccination |
7 |
|
liver biopsy |
7 |
|
living donor |
7 |
|
living donor liver transplantation |
7 |
|
long-term survival |
7 |
|
mafld |
7 |
|
metabolic syndrome |
7 |
|
nafld |
7 |
|
retransplantation |
7 |
|
right liver graft |
7 |
|
small-for-size syndrome |
7 |
|
survival outcomes |
7 |
|
vcte |
7 |
|
artificial intelligence |
6 |
|
computed tomography |
6 |
|
cytokines |
6 |
|
deep learning |
6 |
|
hepatic surgery |
6 |
|
inflammation |
6 |
|
post-lt surveillance |
6 |
|
primary transplantation |
6 |
|
propensity score matching |
6 |
|
salvage transplantation |
6 |
|
survival |
6 |
|
tumor recurrence |
6 |
|
blood transfusion |
5 |
|
complications |
5 |
|
hepatectomy |
5 |
|
immunosuppression |
5 |
|
liver resection |
5 |
|
acute rejection |
4 |
|
acute-on-chronic liver failure |
4 |
|
alpha-fetoprotein |
4 |
|
deceased donor liver transplant |
4 |
|
liver transplant |
4 |
|
living donor liver transplant |
4 |
|
living-donor liver transplantation |
4 |
|
adoptive immunity transfer |
3 |
|
alemtuzumab |
3 |
|
anatomy |
3 |
|
antiviral therapy |
3 |
|
belatacept |
3 |
|
bridging therapy |
3 |
|
calcineurin inhibitor |
3 |
|
corticosteroid |
3 |
|
cyclosporine |
3 |
|
everolimus |
3 |
|
hbv vaccination |
3 |
|
hepatitis b |
3 |
|
hepatitis b immune globulin |
3 |
|
mtor inhibitor |
3 |
|
mycophenolate |
3 |
|
recurrence |
3 |
|
sirolimus |
3 |
|
sotrastaurin |
3 |
|
surgical procedure |
3 |
|
tacrolimus |
3 |
|
targeted therapy |
3 |
|
therapeutics |
3 |
|
tofacitinib |
3 |
|
transarterial chemoembolisation |
3 |
|
transarterial radioembolisation |
3 |
|
treg |
3 |
|
voclosporin |
3 |
|
asia |
2 |
|
bile leak |
2 |
|
biliary anastomotic stricture |
2 |
|
biliary complications |
2 |
|
bloodless liver resection |
2 |
|
cancer growth |
2 |
|
cancer recurrence |
2 |
|
cholangiocarcinoma |
2 |
|
deceased donor |
2 |
|
disease progression |
2 |
|
human |
2 |
|
liver cell carcinoma |
2 |
|
loco-regional therapy |
2 |
|
mrecist |
2 |
|
resection strategy |
2 |
|
tumor burden score |
2 |
|
abdominal pain - etiology |
1 |
|
acute disease |
1 |
|
aged |
1 |
|
angiography - methods |
1 |
|
appendectomy |
1 |
|
appendectomy - methods |
1 |
|
appendicitis - surgery |
1 |
|
atrial fibrillation - complications |
1 |
|
carcinoma, hepatocellular - pathology - secondary - surgery |
1 |
|
carcinoma, squamous cell - physiopathology - therapy |
1 |
|
case-control studies |
1 |
|
cause of death - trends |
1 |
|
celiac artery - radiography |
1 |
|
cohort studies |
1 |
|
combined modality therapy |
1 |
|
deglutition |
1 |
|
duodenal ulcer - therapy |
1 |
|
duodenum - blood supply |
1 |
|
embolism - etiology - radiography |
1 |
|
embolization, therapeutic - methods |
1 |
|
esophageal neoplasms - physiopathology - therapy |
1 |
|
esophagectomy |
1 |
|
female |
1 |
|
head and neck cancer |
1 |
|
hemostasis, endoscopic |
1 |
|
hong kong - epidemiology |
1 |
|
humans |
1 |
|
infarction - etiology - radiography |
1 |
|
kidney - blood supply |
1 |
|
kidney neoplasms - pathology - secondary - surgery |
1 |
|
l-lactate dehydrogenase - metabolism |
1 |
|
laparoendoscopic single-site surgery |
1 |
|
laparoscopes |
1 |
|
laparoscopy - methods |
1 |
|
late recurrence |
1 |
|
length of stay |
1 |
|
liver neoplasms |
1 |
|
male |
1 |
|
metastasis |
1 |
|
middle aged |
1 |
|
peptic ulcer hemorrhage - mortality - radiography - therapy |
1 |
|
postoperative care |
1 |
|
postoperative complications |
1 |
|
push-type percutaneous endoscopic gastrostomy |
1 |
|
quality of life |
1 |
|
recovery of function |
1 |
|
renal artery obstruction - etiology - radiography |
1 |
|
reoperation |
1 |
|
retroperitoneal |
1 |
|
retroperitoneal neoplasms - pathology - secondary - surgery |
1 |
|
retrospective studies |
1 |
|
sils |
1 |
|
single-incision laparoscopic surgery |
1 |
|
single-port access |
1 |
|
single-site-access laparoscopic surgery |
1 |
|
stomach - blood supply |
1 |
|
survival rate - trends |
1 |
|
time factors |
1 |
|
tomography, x-ray computed |
1 |
|
treatment failure |
1 |
|
treatment outcome |
1 |
|
trismus |
1 |
|
tube feeding |
1 |
